Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

NCT02626507 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gedatolisib
DRUG: Faslodex
DRUG: Palbociclib
DRUG: Zoladex

Sponsor

Hoffman Oncology

Collaborators

[object Object]